Mostly all chemotherapeutic agents fail to induce programmed cell death when there is no functional p53 in most human cancer cells (4), so p53- independent apoptosis caused by the NS1 gene of CPV2 can serve as a beneficial therapeutic approach in such cancers. Here, TP53 is linked to cancer.